Granisetron and ondansetron for chemotherapy-related nausea and vomiting

Haematologia

Volumn 29, Issue 1, 1998, Pages 25-31

  Zeidman, Aliza ^a   Ben Dayan, Daniele ^a   Ben Zion, Tzippy ^a   Kaufman, Oren ^a   Cohen, Amos M ^a   Mittelman, Moshe ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b HASHARON HOSPITAL   (Israel)

Author keywords

5 HT3 antagonists; Chemotherapy induced emesis; Granisetron; Ondansetron

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; GRANISETRON; ONDANSETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN ANTAGONIST;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NAUSEA; ORAL DRUG ADMINISTRATION; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

ANTIEMETICS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; GRANISETRON; HUMANS; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; ONDANSETRON; TREATMENT OUTCOME; VOMITING;

EID: 7344248598     PISSN: 00176559     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Del Favero, A., Roila, F., Tonato, M.: Reducing chemotherapy induced nausea and vomiting: current perspectives and future possibilities. Drug Safety 9, 410 (1993).
2. Marty, M.: A comparative study of the use of granisetron, a selective 5-HT3 antagonists, versus a standard antiemetic regimen of chlorpromazine plus dexamethasone in the treatment of cytostatic induced emesis. Eur. J. Cancer 26, 28 (1990).
3. Hasketh, P. J., Kris, M. G., Grunberg, S. M. et al.: Proposal for classifying the acute emetogenicity of cancer chemotherapy. J. Clin. Oncol. 15, 103 (1997).
4. Navari, R. M., Plezia, P., Kaplan, H. G.: Single dose, double blind, multicenter study evaluation of the efficacy and safety of intravenous granisetron in the prevention of cisplatin induced nausea and vomiting. Proc. Am. Soc. Clin. Oncol. 12, 1511 (1993).
5. Jantunen, I. T., Muhonen, V. V., Kataja, M. K. et al.: 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy - a randomized study. Eur. J. Cancer 29, 1669 (1993).
6. Levitt, M., Warr, D., Yele, L. et al.: Ondansetron compared with dexamethasone and metoclopramide as antiemetic in the chemotherapy of breast cancer with cyclophosphamide, methotrexate, and flourouracil. N. Eng. J. Med. 328, 1081 (1993).
7. Hesketh, P. J., Harvey, W. H., Harker, W. G. et al.: A randomized, double blind comparision of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high dose cisplatin induced emesis. J. Clin. Oncol. 12, 596 (1994).
8. Plosker, G. L., Goa, L. K.: Granisetron: a review of its pharmacological properties and therapeutic use as antiemetic. Drugs 42, 805 (1991).
9. The Italian group for the antiemetic research: Dexamethasone, granisetron or both for the prevention of nausea and vomiting during chemotherapy for cancer. N. Eng. J. Med. 332, 1 (1995).
10. Bonnetere, J., Hacquet, B.: Granisetron IV compared with ondansetron IV plus tablets in the prevention of nausea and vomiting induced by a moderately emetogenic chemotherapy regimen: A randomized cross over study. ECCO 7 Jerusalem 22, 1-3 (1993).
11. Dilly, S. G.: A double blind crossover study to compare the efficacy and safety of granisetron and ondansetron in the prophylaxis of nausea and vomiting induced by 5 day fractionated chemotherapy. ECCO 7 Jerusalem 25, 1-3 (1993).
12. Sanger, G. J.: New antiemetic drugs. Can. J. Physiol. Pharmacol. 68, 314 (1990).
13. Hanson, J. C., McCallum, R. W.: The diagnosis and management of nausea and vomiting. Am. J. Gastroent. 80, 210 (1985).
14. Soukop, M., McQuade, B., Hunter, E. et al.: Ondansetron compared with metoclopramide in the control of emesis and quality of life during repeated chemotherapy for breast cancer. Oncology 49, 295 (1992).
15. Marschner, N. W., Adler, M., Nagel, G. A. et al.: Double blind randomized trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide. Eur. J. Cancer 27, 1137 (1991).
16. Soukop, M.: A dose finding study of granisetron, a novel antiemetic, in patients receiving high dose cisplatin. Suppor. Care. Can. 3, 177 (1994).
17. Blieberg, H. H., Spielmann, M., Falkson, G., Romain, D.: Antiemetic treatment with oral granisetron in patients receiving moderately emetogenic chemotherapy: A dose ranging study. Clin. Therap. 17, 38 (1995).